Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000733499 | SCV000861576 | uncertain significance | not provided | 2018-06-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001427357 | SCV001630032 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003303220 | SCV004005977 | likely benign | Cardiovascular phenotype | 2023-05-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004535868 | SCV004730667 | likely benign | TTN-related disorder | 2019-05-02 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |